U.S., July 8 -- ClinicalTrials.gov registry received information related to the study (NCT07687147) titled 'Daily Adjustment of the Radiation Dose in MRI-guided Stereotactic Radiotherapy for Tumors in the Abdominal and Pelvic Regions' on April 30.
Brief Summary: SBRT delivers high-dose radiation to precisely defined target volumes and is an effective locally ablative treatment option for both primary tumours and oligometastases in various settings, including lesions in the abdomen or pelvis. However, SBRT in these regions faces considerable challenges such as inter-fractional organ motion and anatomical deformation, which can compromise treatment precision.
MR-guided SBRT offers a solution, providing superior soft-tissue contrast and enab...